Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series
We’re pleased to share that Jim Sage, Global CEO and President of Inizio Engage, has been featured in pharmaphorum’s latest “12 Questions” interview series.
In the conversation, Jim reflects on his career across international markets, his motivations as a leader, and the experiences that have shaped his approach to building high-performing teams. He also explores some of the most pressing challenges facing the pharmaceutical industry today, including pricing pressures, launch performance, and the need for new reimbursement models.
Jim highlights how data, technology, and AI are already transforming the way organisations operate, and discusses the growing importance of patient-centric approaches, from HUB services to personalised support throughout the treatment journey.
Jump to a slide with the slide dots.
Inizio Ignite Sparks a New Era of Connected Advisory Solutions
Inizio Ignite brings together Research Partnership, Putnam, Vynamic, and STEM.
Read moreLaunch Readiness Reimagined: Takeaways from Pharma Launch Excellence (PHLEX) summit 2025
PHLEX Summit 2025 reveals how early alignment, agile planning, real-world insights, and AI are reshaping pharma launch excellence.
Read moreInizio launches InConcert™ to transform pre-launch planning through connected intelligence.
Introducing InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase.
Read more